Alacris-CMTA® Diagnostic Service
Precision Oncology (Various Cancers)
Key Facts
About Alacris Theranostics
Alacris Theranostics is a privately held, revenue-generating service provider and diagnostics company operating at the intersection of genomics, oncology, and AI/machine learning. Its core offering is the Alacris-CMTA® platform, a deep comprehensive genomic profiling service that combines whole exome/genome sequencing with deep bulk transcriptomics for precision oncology diagnostics, operating within an ISO 15189:2024 accredited laboratory. Beyond its clinical diagnostics service, the company provides a full suite of scalable, end-to-end NGS and bioinformatics services for research and pharma, supported by a strong track record in EU-funded research consortia. Alacris is positioned as a specialized partner translating complex omics data into real-world benefits for personalized patient care and research discovery.
View full company profile